Analysis of tumor-infiltrating lymphocytes (TILs) showed that more CD4, CD8, neutrophil, macrophages, and dendritic cells were detected in high prognostic risk LUSC patients compared to low prognostic risk LUSC patients [64]. The gene discussed is CD8A; the disease is neoplasm.